Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism

2006 ◽  
Vol 28 (2) ◽  
pp. 111-116 ◽  
Author(s):  
Z. J. JUN ◽  
T. PING ◽  
Y. LEI ◽  
L. LI ◽  
S. Y. MING ◽  
...  
2006 ◽  
Vol 81 (8) ◽  
pp. 641-643 ◽  
Author(s):  
Lobna Bouaziz-Borgi ◽  
Wassim Y. Almawi ◽  
Nabil Mtiraoui ◽  
Brahim Nsiri ◽  
Sose H. Keleshian ◽  
...  

2005 ◽  
Vol 94 (11) ◽  
pp. 965-968 ◽  
Author(s):  
Philippe de Mazancourt ◽  
Ghassan Maghzal ◽  
Stephen Brennan ◽  
Michael Mosesson ◽  
Emmanuelle de Raucourt

SummaryWe have identified a novel heterozygous fibrinogen γ chain mutation, γN345S (Fibrinogen Saint-Germain II), in a subject with hypofibrinogenemia. There was no evidence by mass spectrometry of plasma fibrinogen containing the mutant chain. The hypofibrinogenemia was discovered in a 26-year-old man who experienced extensive deep venous thrombosis of the left leg associated with pulmonary embolism. Investigation of potential thromboembolic risk factors revealed heterozygosity of the factor V R506Q mutation (factor V Leiden) and heterozygosity of the prothrombin gene G20210A mutation. The hypofibrinogenemia may be contributory to the thrombophilic manifestations.


1996 ◽  
Vol 131 (6) ◽  
pp. 1145-1148 ◽  
Author(s):  
Denise R. Hirsch ◽  
Katriina M. Mikkola ◽  
Peter W. Marks ◽  
Edward A. Fox ◽  
David M. Dorfman ◽  
...  

2006 ◽  
Vol 21 (1) ◽  
pp. 24-27 ◽  
Author(s):  
A Mansilha ◽  
F Araújo ◽  
M Severo ◽  
S M Sampaio ◽  
T Toledo ◽  
...  

Objective: To evaluate the association between the Factor V Leiden (FV R506Q) and prothrombin gene (FII G20210A) mutations and deep venous thrombosis (DVT) in young people. Methods: Blood samples were drawn from 199 subjects: 100 healthy controls and 99 unselected patients, with an objectively documented first episode of DVT under 40 years old. DNA analysis was performed using the polymerase chain reaction. Results: The mean age in the patient cohort was 27 years (range 16–40) and 68 (68.7%) were women. Patient prevalences were 20.6% and 10.1% for FV R506Q and FII G20210A, respectively. In the control group, carrier frequencies were 2% and 5%, respectively. We found an increased overall relative risk of DVT with statistical significance for FV R506Q carriers (OR: 12.8; 95% CI: 2.9–56.7; P < 0.001), but not for FII G20210A mutation (OR: 2.1; 95% CI: 0.7–6.5; P = 0.19). Conclusions: Our results suggest a possible increase in DVT risk for the young G20210A allele carriers, which can be more expressed in the presence of a circumstantial risk factor. There is extremely strong evidence that the Factor V Leiden mutation is an important risk factor in the development of a first episode of DVT in young people.


Sign in / Sign up

Export Citation Format

Share Document